의료 물류 시장 : 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of healthcare logistics Market

The global healthcare logistics market was valued at USD 102.54 billion in 2025 and is projected to grow from USD 107.62 billion in 2026 to USD 163.59 billion by 2034, registering a CAGR of 5.4% during the forecast period. North America dominated the healthcare logistics market with a 37.28% market share in 2025, driven by advanced healthcare infrastructure, strong pharmaceutical manufacturing, and widespread adoption of temperature-controlled logistics solutions.

Healthcare logistics involves the secure transportation, warehousing, inventory management, and distribution of pharmaceuticals, medical devices, vaccines, biologics, laboratory samples, and clinical trial materials. Rising clinical trial activity, increasing demand for specialty medicines, growing pharmaceutical outsourcing, and the expansion of direct-to-patient delivery services are accelerating market growth worldwide. Moreover, investments in cold-chain infrastructure and digital supply chain technologies are improving operational efficiency across healthcare logistics networks.

Healthcare Logistics Market Trends

One of the major trends shaping the healthcare logistics market is the increasing adoption of real-time temperature monitoring technologies. Pharmaceutical manufacturers and logistics providers are increasingly deploying IoT-enabled sensors, GPS tracking, RFID devices, cloud-based monitoring platforms, and automated alerts to ensure product integrity throughout transportation and storage.

The growing demand for biologics, vaccines, cell and gene therapies, and other temperature-sensitive medicines has increased the need for advanced cold-chain logistics. These technologies provide continuous visibility into temperature, humidity, route deviations, and shipment conditions, reducing product losses and ensuring compliance with regulatory standards.

Market Drivers

The growing number of clinical trials worldwide is a major factor driving healthcare logistics demand. Pharmaceutical, biotechnology, and medical device companies require specialized logistics services for transporting clinical trial materials, biological samples, investigational drugs, and laboratory equipment across multiple countries.

Increasing investments in pharmaceutical research and development, coupled with expanding outsourcing activities, are generating strong demand for warehousing, distribution, and temperature-controlled transportation services. The continuous expansion of pharmaceutical manufacturing and specialty medicine production further supports long-term market growth.

Market Restraints

The high cost of cold-chain infrastructure remains one of the biggest challenges for healthcare logistics providers. Maintaining validated refrigerated warehouses, specialized transportation fleets, backup power systems, monitoring equipment, and regulatory compliance significantly increases operational expenses.

These high infrastructure costs create barriers for small and medium-sized logistics companies while increasing overall supply chain costs for pharmaceutical manufacturers and healthcare providers.

Market Opportunities

The rapid expansion of pharmaceutical cold-chain networks presents significant opportunities for market participants. Growing demand for vaccines, biologics, insulin, oncology therapies, and advanced biologic medicines is encouraging investments in specialized refrigerated transportation, validated storage facilities, and smart packaging technologies.

Increasing healthcare expenditure across emerging economies and expanding pharmaceutical exports are further creating new growth opportunities for healthcare logistics providers.

Market Challenges

Limited healthcare infrastructure and a relatively low number of clinical trials in several developing countries continue to restrict market expansion. Weak transportation networks, insufficient cold-chain facilities, limited logistics service providers, and underdeveloped pharmaceutical ecosystems reduce demand for advanced healthcare logistics services in these regions.

Market Segmentation

Based on service type, the market is segmented into transportation services, warehousing & storage services, distribution services, and others. Transportation services dominated the market in 2025 due to rising pharmaceutical shipments, diagnostic testing volumes, and increasing movement of laboratory samples. Distribution services are expected to witness steady future growth.

By product type, the market includes pharmaceutical products, medical devices, clinical trial materials, and others. Pharmaceutical products accounted for the largest market share of 46.7% in 2025, supported by increasing drug production, biologics manufacturing, and clinical research activities.

Based on temperature control, the market is categorized into cold-chain logistics and non-cold-chain logistics. Non-cold-chain logistics held the largest share in 2025 due to the high volume of generic medicines requiring ambient storage, while cold-chain logistics is projected to experience faster growth during the forecast period.

By logistics model, the market is divided into in-house and outsourced services. The outsourced segment dominated in 2025 as pharmaceutical companies increasingly relied on third-party logistics providers to reduce infrastructure costs and access specialized cold-chain capabilities.

Based on end user, the market comprises pharmaceutical & biotechnology companies, medical device companies, hospitals & clinics, and others. Pharmaceutical and biotechnology companies remained the leading end-user segment owing to expanding drug manufacturing, vaccine production, and increasing clinical research activities.

Regional Outlook

North America remained the largest regional market with a value of USD 38.23 billion in 2025, supported by robust pharmaceutical production, advanced healthcare infrastructure, and a high volume of clinical trials. The U.S. continues to represent the largest national market within the region.

Europe is expected to witness stable growth due to increasing pharmaceutical distribution activities, stronger inventory management systems, and expanding healthcare supply chains. Germany and the U.K. remain key contributors to regional growth.

Asia Pacific is emerging as one of the fastest-growing markets owing to expanding pharmaceutical manufacturing, improving healthcare infrastructure, increasing regulatory compliance, and growing investments in temperature-controlled logistics across China, India, and Japan.

Latin America and the Middle East & Africa are projected to record moderate growth as healthcare investments, pharmaceutical distribution networks, and cold-chain capabilities continue to improve across these regions.

Competitive Landscape

The healthcare logistics market remains highly competitive with global logistics providers focusing on expanding cold-chain infrastructure, pharmaceutical warehousing, and specialized healthcare transportation services. Companies are investing in strategic partnerships, acquisitions, and facility expansions to strengthen their market presence.

Major companies operating in the market include DHL Group, United Parcel Service of America (UPS), FedEx, Kuehne+Nagel, DB Schenker, DSV, CEVA Logistics, GEODIS, Cencora Inc., and Marken. These organizations continue expanding temperature-controlled logistics networks and pharmaceutical distribution capabilities to meet the growing global demand.

Key Industry Developments

• May 2026: Kuehne+Nagel opened a new temperature-controlled airfreight cross-dock facility in Hyderabad to strengthen its healthcare logistics operations.
• May 2026: Kuehne+Nagel signed a five-year logistics partnership agreement with MHC Group to enhance its logistics service portfolio.
• April 2026: GEODIS launched a dedicated healthcare cold-chain cross-dock facility across the Americas to strengthen pharmaceutical logistics capabilities.
• March 2026: DHL Group expanded DHL Health Logistics by developing a pharmaceutical hub in Singapore, supporting global life sciences and healthcare logistics.
• April 2025: CEVA Logistics announced the construction of a new pharmaceutical logistics warehouse at Strasbourg-Entzheim Airport Business Park to expand its healthcare logistics network.

Conclusion

The global healthcare logistics market is positioned for steady long-term growth, supported by expanding pharmaceutical manufacturing, increasing clinical trials, rising biologics and vaccine distribution, and greater adoption of advanced cold-chain technologies. Continuous investments in temperature-controlled infrastructure, digital tracking systems, and specialized logistics services will strengthen supply chain efficiency while supporting the safe delivery of healthcare products worldwide. With growing healthcare demand across both developed and emerging economies, healthcare logistics providers are expected to play an increasingly critical role in ensuring secure, compliant, and efficient medical supply chains through 2034.

Segmentation By Service Type, Product Type, Temperature Control, Logistics Model, End User, and Region

By Service Type * Transportation Services

• Warehousing & Storage Services
• Distribution Services
• Others

By Product Type * Pharmaceutical Products

• Medical Devices
• Clinical Trial Materials
• Others

By Temperature Control * Cold Chain Logistics

• Non-cold Chain Logistics

By Logistics Model * In-house

• Outsourced

By End User * Pharmaceutical & Biotechnological Companies

• Medical Device Companies
• Hospitals & Clinics
• Others

By Region * North America (By Service Type, By Product Type, By Temperature Control, By Logistics Model, By End User, and by Country)

• U.S. (By Temperature Control)
• Canada (By Temperature Control)
• Europe (By Service Type, By Product Type, By Temperature Control, By Logistics Model, By End User, and by Country/Sub-region)
  • U.K. (By Temperature Control)
  • Germany (By Temperature Control)
  • France (By Temperature Control)
  • Italy (By Temperature Control)
  • Spain (By Temperature Control)
  • Scandinavia (By Temperature Control)
  • Rest of Europe (By Temperature Control)
• Asia Pacific (By Service Type, By Product Type, By Temperature Control, By Logistics Model, By End User, and by Country/Sub-region)
  • China (By Temperature Control)
  • Japan (By Temperature Control)
  • India (By Temperature Control)
  • Australia (By Temperature Control)
  • Southeast Asia (By Temperature Control)
  • Rest of Asia Pacific (By Temperature Control)
• Latin America (By Service Type, By Product Type, By Temperature Control, By Logistics Model, By End User, and by Country/Sub-region)
  • Brazil (By Temperature Control)
  • Mexico (By Temperature Control)
  • Rest of Latin America (By Temperature Control)
• Middle East & Africa (By Service Type, By Product Type, By Temperature Control, By Logistics Model, By End User, and by Country/Sub-region)
  • GCC (By Temperature Control)
  • South Africa (By Temperature Control)
  • Rest of the Middle East & Africa (By Temperature Control)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Challenges
• 3.5. Market Trends

4. Key Insights

• 4.1. Number of Clinical Trials, Key Countries/Regions, 2025
• 4.2. Overview of R&D Expenditures, Key Players
• 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Healthcare Logistics Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Service Type
  • 5.1.1. Transportation Services
  • 5.1.2. Warehousing & Storage Services
  • 5.1.3. Distribution Services
  • 5.1.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Product Type
  • 5.2.1. Pharmaceutical Products
  • 5.2.2. Medical Devices
  • 5.2.3. Clinical Trial Materials
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Temperature Control
  • 5.3.1. Cold Chain Logistics
  • 5.3.2. Non-cold Chain Logistics
• 5.4. Market Analysis, Insights and Forecast - By Logistics Model
  • 5.4.1. In-house
  • 5.4.2. Outsourced
• 5.5. Market Analysis, Insights and Forecast - By End User
  • 5.5.1. Pharmaceutical & Biotechnological Companies
  • 5.5.2. Medical Device Companies
  • 5.5.3. Hospitals & Clinics
  • 5.5.4. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Healthcare Logistics Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Service Type
  • 6.1.1. Transportation Services
  • 6.1.2. Warehousing & Storage Services
  • 6.1.3. Distribution Services
  • 6.1.4. Others
• 6.2. Market Analysis, Insights and Forecast - By Product Type
  • 6.2.1. Pharmaceutical Products
  • 6.2.2. Medical Devices
  • 6.2.3. Clinical Trial Materials
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Temperature Control
  • 6.3.1. Cold Chain Logistics
  • 6.3.2. Non-cold Chain Logistics
• 6.4. Market Analysis, Insights and Forecast - By Logistics Model
  • 6.4.1. In-house
  • 6.4.2. Outsourced
• 6.5. Market Analysis, Insights and Forecast - By End User
  • 6.5.1. Pharmaceutical & Biotechnological Companies
  • 6.5.2. Medical Device Companies
  • 6.5.3. Hospitals & Clinics
  • 6.5.4. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
    • 6.6.1.1. By Temperature Control
  • 6.6.2. Canada
    • 6.6.2.1. By Temperature Control

7. Europe Healthcare Logistics Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Service Type
  • 7.1.1. Transportation Services
  • 7.1.2. Warehousing & Storage Services
  • 7.1.3. Distribution Services
  • 7.1.4. Others
• 7.2. Market Analysis, Insights and Forecast - By Product Type
  • 7.2.1. Pharmaceutical Products
  • 7.2.2. Medical Devices
  • 7.2.3. Clinical Trial Materials
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Temperature Control
  • 7.3.1. Cold Chain Logistics
  • 7.3.2. Non-cold Chain Logistics
• 7.4. Market Analysis, Insights and Forecast - By Logistics Model
  • 7.4.1. In-house
  • 7.4.2. Outsourced
• 7.5. Market Analysis, Insights and Forecast - By End User
  • 7.5.1. Pharmaceutical & Biotechnological Companies
  • 7.5.2. Medical Device Companies
  • 7.5.3. Hospitals & Clinics
  • 7.5.4. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.6.1. U.K.
    • 7.6.1.1. By Temperature Control
  • 7.6.2. Germany
    • 7.6.2.1. By Temperature Control
  • 7.6.3. France
    • 7.6.3.1. By Temperature Control
  • 7.6.4. Spain
    • 7.6.4.1. By Temperature Control
  • 7.6.5. Italy
    • 7.6.5.1. By Temperature Control
  • 7.6.6. Scandinavia
    • 7.6.6.1. By Temperature Control
  • 7.6.7. Rest of Europe
    • 7.6.7.1. By Temperature Control

8. Asia Pacific Healthcare Logistics Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Service Type
  • 8.1.1. Transportation Services
  • 8.1.2. Warehousing & Storage Services
  • 8.1.3. Distribution Services
  • 8.1.4. Others
• 8.2. Market Analysis, Insights and Forecast - By Product Type
  • 8.2.1. Pharmaceutical Products
  • 8.2.2. Medical Devices
  • 8.2.3. Clinical Trial Materials
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Temperature Control
  • 8.3.1. Cold Chain Logistics
  • 8.3.2. Non-cold Chain Logistics
• 8.4. Market Analysis, Insights and Forecast - By Logistics Model
  • 8.4.1. In-house
  • 8.4.2. Outsourced
• 8.5. Market Analysis, Insights and Forecast - By End User
  • 8.5.1. Pharmaceutical & Biotechnological Companies
  • 8.5.2. Medical Device Companies
  • 8.5.3. Hospitals & Clinics
  • 8.5.4. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.6.1. Japan
    • 8.6.1.1. By Temperature Control
  • 8.6.2. Australia
    • 8.6.2.1. By Temperature Control
  • 8.6.3. China
    • 8.6.3.1. By Temperature Control
  • 8.6.4. India
    • 8.6.4.1. By Temperature Control
  • 8.6.5. Southeast Asia
    • 8.6.5.1. By Temperature Control
  • 8.6.6. Rest of Asia Pacific
    • 8.6.6.1. By Temperature Control

9. Latin America Healthcare Logistics Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Service Type
  • 9.1.1. Transportation Services
  • 9.1.2. Warehousing & Storage Services
  • 9.1.3. Distribution Services
  • 9.1.4. Others
• 9.2. Market Analysis, Insights and Forecast - By Product Type
  • 9.2.1. Pharmaceutical Products
  • 9.2.2. Medical Devices
  • 9.2.3. Clinical Trial Materials
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Temperature Control
  • 9.3.1. Cold Chain Logistics
  • 9.3.2. Non-cold Chain Logistics
• 9.4. Market Analysis, Insights and Forecast - By Logistics Model
  • 9.4.1. In-house
  • 9.4.2. Outsourced
• 9.5. Market Analysis, Insights and Forecast - By End User
  • 9.5.1. Pharmaceutical & Biotechnological Companies
  • 9.5.2. Medical Device Companies
  • 9.5.3. Hospitals & Clinics
  • 9.5.4. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.6.1. Brazil
    • 9.6.1.1. By Temperature Control
  • 9.6.2. Mexico
    • 9.6.2.1. By Temperature Control
  • 9.6.3. Rest of Latin America
    • 9.6.3.1. By Temperature Control

10. Middle East & Africa Healthcare Logistics Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Service Type
  • 10.1.1. Transportation Services
  • 10.1.2. Warehousing & Storage Services
  • 10.1.3. Distribution Services
  • 10.1.4. Others
• 10.2. Market Analysis, Insights and Forecast - By Product Type
  • 10.2.1. Pharmaceutical Products
  • 10.2.2. Medical Devices
  • 10.2.3. Clinical Trial Materials
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Temperature Control
  • 10.3.1. Cold Chain Logistics
  • 10.3.2. Non-cold Chain Logistics
• 10.4. Market Analysis, Insights and Forecast - By Logistics Model
  • 10.4.1. In-house
  • 10.4.2. Outsourced
• 10.5. Market Analysis, Insights and Forecast - By End User
  • 10.5.1. Pharmaceutical & Biotechnological Companies
  • 10.5.2. Medical Device Companies
  • 10.5.3. Hospitals & Clinics
  • 10.5.4. Others
• 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.6.1. GCC
    • 10.6.1.1. By Temperature Control
  • 10.6.2. South Africa
    • 10.6.2.1. By Temperature Control
  • 10.6.3. Rest of Middle East & Africa
    • 10.6.3.1. By Temperature Control

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. DHL Group
  • 11.2.2. United Parcel Service of America, Inc.
  • 11.2.3. FedEx
  • 11.2.4. Kuehne+Nagel
  • 11.2.5. DB SCHENKER
  • 11.2.6. DSV
  • 11.2.7. CEVA Logistics
  • 11.2.8. GEODIS
  • 11.2.9. Cencora, Inc.
  • 11.2.10. Marken